On May 1, the third phase of the 139th China Import and Export Fair (Canton Fair) grandly opened at the Pazhou International Exhibition Center in Guangzhou. As a global leader in home health management products and an innovator in pulse oximetry, ChoiceMMed showcased its diverse portfolio of innovative products in respiratory health, oxygen saturation monitoring, cardiovascular health, and primary care at Booth 9.2D04. The exhibition demonstrated the company’s strong commitment to smart healthcare solutions to buyers and industry partners from around the world.

Spanning a total exhibition area of 1.55 million square meters with 75,700 booths and over 32,000 participating companies, this edition of the Canton Fair reached a record scale. The third phase, themed “Better Life” featured a dedicated Smart Healthcare zone, highlighting innovations in disease diagnosis and treatment, rehabilitation nursing, and health management.It provided an efficient platform for medical technology companies to connect with global markets. 

On the opening day, ChoiceMMed’s booth attracted a steady stream of overseas buyers and professional visitors. The lively atmosphere drew particular interest from purchasers across Southeast Asia, the Middle East, Europe, and Latin America, who came to explore the company’s cutting-edge medical innovations and technical solutions.

At this year’s fair, ChoiceMMed presented a range of products including oxygen concentrators, portable oxygen concentrators, compact hydrogen generator, and nebulizers. In cardiovascular health, the company featured card-sized portable devices such as card ECG monitor. For oxygen monitoring, the company exhibited a wide variety of devices including wrist-worn, handheld, finger-clip, and tabletop pulse oximeters, as well as chronic disease management oximeters, telemedicine oximeters, and various oximetry probes. A buyer from the Middle East praised ChoiceMMed’s smart health management solutions at the booth, saying, “ChoiceMMed’s products are not only intuitive to operate and accurate in data, but also highly suitable for the daily monitoring needs of local households and community clinics, offering a truly reliable solution for everyday health management. ”  

In recent years, ChoiceMMed has actively aligned with the Belt and Road Initiative, deepening healthcare collaboration with partner countries. At this year’s Canton Fair, over 120,000 buyers from Belt and Road countries participated, marking a significant increase from previous editions. Through the fair, ChoiceMMed continues to support healthcare development in these regions, working with local partners to implement smart healthcare solutions and enhance regional health services. 

As a wholly-owned subsidiary of Tianjin Chasesun Pharmaceutical Co., Ltd. , ChoiceMMed leverages its strengths in intelligent, portable, and wearable medical devices, while continuously innovating with internet, big data, and AI technologies. Guided by Chasesun’s strategic vision, ChoiceMMed will further expand its global footprint, driving high-quality development through market-driven innovation and delivering better healthcare products and services to users worldwide.